Format
Sort by
Items per page

Send to

Choose Destination

Best matches for Lütticken R[au]:

[Lectins and the organotropy of metastasis]. Uhlenbruck G et al. Dtsch Med Wochenschr. (1986)

Similar environmental survival patterns of Streptococcus pyogenes strains of different epidemiologic backgrounds and clinical severity. Wagenvoort JH et al. Eur J Clin Microbiol Infect Dis. (2005)

Enterococcus raffinosus infection in an immunosuppressed patient: case report and review of the literature. Freyaldenhoven BS et al. J Infect. (2005)

Search results

Items: 1 to 50 of 132

1.

Microbiological investigation of a hospital outbreak of invasive group A streptococcal disease in Krakow, Poland.

Strus M, Drzewiecki A, Chmielarczyk A, Tomusiak A, Romanek P, Kosowski K, Kochan P, van der Linden M, Lütticken R, Heczko PB.

Clin Microbiol Infect. 2010 Sep;16(9):1442-7. doi: 10.1111/j.1469-0691.2009.03139.x.

2.

Rapid detection of Streptococcus agalactiae from swabs by peptide nucleic acid fluorescence in situ hybridization.

Peltroche-Llacsahuanga H, Fiandaca MJ, von Oy S, Lütticken R, Haase G.

J Med Microbiol. 2010 Feb;59(Pt 2):179-84. doi: 10.1099/jmm.0.013995-0. Epub 2009 Oct 15.

PMID:
19833782
3.

Comparison of two chromogenic media for selective isolation of vancomycin-resistant enterococci from stool specimens.

Peltroche-Llacsahuanga H, Top J, Weber-Heynemann J, Lütticken R, Haase G.

J Clin Microbiol. 2009 Dec;47(12):4113-6. doi: 10.1128/JCM.00882-09. Epub 2009 Oct 7.

4.

Epidemiology of invasive Streptococcus pyogenes infections in Germany, 1996-2002: results from a voluntary laboratory surveillance system.

Wahl RU, Lütticken R, Stanzel S, van der Linden M, Reinert RR.

Clin Microbiol Infect. 2007 Dec;13(12):1173-8. Epub 2007 Sep 10.

5.

A new closed-tube multiplex real-time PCR to detect eleven superantigens of Streptococcus pyogenes identifies a strain without superantigen activity.

Lintges M, Arlt S, Uciechowski P, Plümäkers B, Reinert RR, Al-Lahham A, Lütticken R, Rink L.

Int J Med Microbiol. 2007 Oct;297(6):471-8. Epub 2007 May 3.

PMID:
17481952
6.

Epidemiology of Streptococcus agalactiae colonization in Germany.

Brimil N, Barthell E, Heindrichs U, Kuhn M, Lütticken R, Spellerberg B.

Int J Med Microbiol. 2006 Feb;296(1):39-44. Epub 2005 Dec 19.

PMID:
16361113
7.

Lack of mitogenic activity of speG- and speG(dys)-positive Streptococcus dysgalactiae subspecies equisimilis isolates from patients with invasive infections.

Brandt CM, Schweizer KG, Holland R, Lütticken R, Freyaldenhoven BS.

Int J Med Microbiol. 2005 Dec;295(8):539-46. Epub 2005 Oct 20.

PMID:
16325550
8.

Enterococcus raffinosus infection in an immunosuppressed patient: case report and review of the literature.

Freyaldenhoven BS, Schlieper G, Lütticken R, Reinert RR.

J Infect. 2005 Oct;51(3):e121-4. Epub 2004 Nov 21. Review.

PMID:
16230189
9.

Evaluation of postdischarge surveillance of surgical site infections after total hip and knee arthroplasty.

Huenger F, Schmachtenberg A, Haefner H, Zolldann D, Nowicki K, Wirtz DC, Bläsius K, Lütticken R, Lemmen SW.

Am J Infect Control. 2005 Oct;33(8):455-62.

PMID:
16216659
10.

Surveillance of nosocomial infections in a neurologic intensive care unit.

Zolldann D, Spitzer C, Häfner H, Waitschies B, Klein W, Sohr D, Block F, Lütticken R, Lemmen SW.

Infect Control Hosp Epidemiol. 2005 Aug;26(8):726-31.

PMID:
16156331
11.

Periodic surveillance of nosocomial infections in a neurosurgery intensive care unit.

Zolldann D, Thiex R, Häfner H, Waitschies B, Lütticken R, Lemmen SW.

Infection. 2005 Jun;33(3):115-21.

PMID:
15940411
12.

Similar environmental survival patterns of Streptococcus pyogenes strains of different epidemiologic backgrounds and clinical severity.

Wagenvoort JH, Penders RJ, Davies BI, Lütticken R.

Eur J Clin Microbiol Infect Dis. 2005 Jan;24(1):65-7. Review. No abstract available.

PMID:
15599644
14.

Antimicrobial resistance of Streptococcus pneumoniae isolates of outpatients in Germany, 1999-2000.

Reinert RR, Lütticken R, Reinert S, Al-Lahham A, Lemmen S.

Chemotherapy. 2004 Oct;50(4):184-9. Epub 2004 Sep 3.

PMID:
15347911
15.

Molecular characterisation of macrolide resistance mechanisms of Streptococcus pneumoniae and Streptococcus pyogenes isolated in Germany, 2002-2003.

Reinert RR, Franken C, van der Linden M, Lütticken R, Cil M, Al-Lahham A.

Int J Antimicrob Agents. 2004 Jul;24(1):43-7.

PMID:
15225860
16.

High-level fluoroquinolone resistance in a clinical Streptoccoccus pyogenes isolate in Germany.

Reinert RR, Lütticken R, Al-Lahham A.

Clin Microbiol Infect. 2004 Jul;10(7):659-62.

17.

HMG-CoA reductase inhibitor simvastatin profoundly improves survival in a murine model of sepsis.

Merx MW, Liehn EA, Janssens U, Lütticken R, Schrader J, Hanrath P, Weber C.

Circulation. 2004 Jun 1;109(21):2560-5. Epub 2004 May 3.

PMID:
15123521
18.
19.

Clonal relatedness of erythromycin-resistant Streptococcus pyogenes isolates in Germany.

Reinert RR, Lütticken R, Sutcliffe JA, Tait-Kamradt A, Cil MY, Schorn HM, Bryskier A, Al-Lahham A.

Antimicrob Agents Chemother. 2004 Apr;48(4):1369-73.

20.

Distribution of multi-resistant Gram-negative versus Gram-positive bacteria in the hospital inanimate environment.

Lemmen SW, Häfner H, Zolldann D, Stanzel S, Lütticken R.

J Hosp Infect. 2004 Mar;56(3):191-7.

PMID:
15003666
21.

Streptococcus pyogenes meningitis complicating varicella in a 3-month-old child.

Brandt CM, Kitz R, Lütticken R, Brade V.

Scand J Infect Dis. 2003;35(11-12):876-8.

PMID:
14723366
22.

Characterization of German penicillin non-susceptible serotype 23F pneumococci using multilocus sequence typing.

Reinert RR, Muckel S, Al-Lahham A, Spratt BG, Brueggemann AB, Hakenbeck R, Lütticken R.

J Med Microbiol. 2003 Nov;52(Pt 11):981-7.

PMID:
14532343
23.

Inhibitor of complement, Compstatin, prevents polymer-mediated Mac-1 up-regulation of human neutrophils independent of biomaterial type tested.

Schmidt S, Haase G, Csomor E, Lütticken R, Peltroche-Llacsahuanga H.

J Biomed Mater Res A. 2003 Sep 1;66(3):491-9.

PMID:
12918031
24.

Ribosomal mutations conferring resistance to macrolides in Streptococcus pneumoniae clinical strains isolated in Germany.

Reinert RR, Wild A, Appelbaum P, Lütticken R, Cil MY, Al-Lahham A.

Antimicrob Agents Chemother. 2003 Jul;47(7):2319-22.

25.
26.

drs (Distantly related sic) gene polymorphisms among emm12-type Streptococcus pyogenes isolates.

Brandt CM, Haase G, Spellerberg B, Holland R, Lütticken R.

J Clin Microbiol. 2003 Apr;41(4):1794-7.

27.

Macrolide-resistant Streptococcus pneumoniae and Streptococcus pyogenes in the pediatric population in Germany during 2000-2001.

Reinert RR, Lütticken R, Bryskier A, Al-Lahham A.

Antimicrob Agents Chemother. 2003 Feb;47(2):489-93.

28.

Characterization of clinical Streptococcus pneumoniae strains from Germany with decreased susceptibility to fluoroquinolones.

Reinert RR, Al-Lahham A, Lütticken R, Boos M, Schmitz FJ.

J Antimicrob Chemother. 2002 Jun;49(6):1015-8.

PMID:
12039895
29.

rgf encodes a novel two-component signal transduction system of Streptococcus agalactiae.

Spellerberg B, Rozdzinski E, Martin S, Weber-Heynemann J, Lütticken R.

Infect Immun. 2002 May;70(5):2434-40.

30.

Emergence of macrolide and penicillin resistance among invasive pneumococcal isolates in Germany.

Reinert RR, Al-Lahham A, Lemperle M, Tenholte C, Briefs C, Haupts S, Gerards HH, Lütticken R.

J Antimicrob Chemother. 2002 Jan;49(1):61-8.

PMID:
11751768
31.
32.

Horizontal gene transfer and host specificity of beta-haemolytic streptococci: the role of a putative composite transposon containing scpB and lmb.

Franken C, Haase G, Brandt C, Weber-Heynemann J, Martin S, Lämmler C, Podbielski A, Lütticken R, Spellerberg B.

Mol Microbiol. 2001 Aug;41(4):925-35.

34.

Macrolide resistance in Streptococcus pyogenes isolates from throat infections in the region of Aachen, Germany.

Brandt CM, Honscha M, Truong ND, Holland R, Hövener B, Bryskier A, Lütticken R, Reinert RR.

Microb Drug Resist. 2001 Summer;7(2):165-70.

PMID:
11442342
35.

Typing of Streptococcus pyogenes strains isolated from throat infections in the region of Aachen, Germany.

Brandt CM, Spellerberg B, Honscha M, Truong ND, Hoevener B, Lütticken R.

Infection. 2001 May-Jun;29(3):163-5.

PMID:
11440388
36.

Nationwide German multicenter study on the prevalence of antibiotic resistance in streptococcal blood isolates from neutropenic patients and comparative in vitro activities of quinupristin-dalfopristin and eight other antimicrobials.

Reinert RR, von Eiff C, Kresken M, Brauers J, Hafner D, Al-Lahham A, Schorn H, Lütticken R, Peters G; Multicenter Study on Antibiotic Resistance in Staphylococci and other Gram-positive Cocci (MARS) Study Group.

J Clin Microbiol. 2001 May;39(5):1928-31.

37.

Implementing and evaluating a rotating surveillance system and infection control guidelines in 4 intensive care units.

Lemmen SW, Zolldann D, Gastmeier P, Lütticken R.

Am J Infect Control. 2001 Apr;29(2):89-93.

PMID:
11287875
38.

Increased titers of antibodies against streptococcal M12 and M19 proteins in patients with Tourette's syndrome.

Müller N, Kroll B, Schwarz MJ, Riedel M, Straube A, Lütticken R, Reinert RR, Reineke T, Kühnemund O.

Psychiatry Res. 2001 Mar 25;101(2):187-93.

PMID:
11286821
39.

Comparison of two sampling methods for the detection of gram-positive and gram-negative bacteria in the environment: moistened swabs versus Rodac plates.

Lemmen SW, Häfner H, Zolldann D, Amedick G, Lütticken R.

Int J Hyg Environ Health. 2001 Mar;203(3):245-8.

PMID:
11279821
40.

Assessment of acid production by various human oral micro-organisms when palatinose or leucrose is utilized.

Peltroche-Llacsahuanga H, Hauk CJ, Kock R, Lampert F, Lütticken R, Haase G.

J Dent Res. 2001 Jan;80(1):378-84.

PMID:
11269732
41.
42.

In vitro activity of gemifloxacin against Streptococcus pneumoniae isolates in Germany.

Lemmen S, Al-Lahham A, Lütticken R, Reinert RR.

Chemotherapy. 2001 Mar-Apr;47(2):104-9.

PMID:
11173811
43.

Characterization of consecutive Streptococcus pyogenes isolates from patients with pharyngitis and bacteriological treatment failure: special reference to prtF1 and sic / drs.

Brandt CM, Allerberger F, Spellerberg B, Holland R, Lütticken R, Haase G.

J Infect Dis. 2001 Feb 15;183(4):670-4. Epub 2001 Jan 24.

PMID:
11170997
44.

Comparison of serum bactericidal activity of ceftazidime, ciprofloxacin and meropenem against Stenotrophomonas maltophilia.

Lemmen SW, Häfner H, Reinert RR, Zolldann D, Kümmerer K, Lütticken R.

J Antimicrob Chemother. 2001 Jan;47(1):118-20. No abstract available.

PMID:
11152445
45.
46.

Influence of an infectious disease service on antibiotic prescription behavior and selection of multiresistant pathogens.

Lemmen SW, Häfner H, Kotterik S, Lütticken R, Töpper R.

Infection. 2000 Nov-Dec;28(6):384-7.

PMID:
11139159
47.

In vitro activity of gatifloxacin against Streptococcus pneumoniae isolates in Germany.

Reinert RR, Al-Lahham A, Lemmen S, Lütticken R.

J Antimicrob Chemother. 2000 Nov;46(5):854-6. No abstract available.

PMID:
11062219
48.

Differentiation between Candida dubliniensis and Candida albicans by fatty acid methyl ester analysis using gas-liquid chromatography.

Peltroche-Llacsahuanga H, Schmidt S, Seibold M, Lütticken R, Haase G.

J Clin Microbiol. 2000 Oct;38(10):3696-704.

49.

Phagocytosis, oxidative burst, and killing of Candida dubliniensis and Candida albicans by human neutrophils.

Peltroche-Llacsahuanga H, Schnitzler N, Schmidt S, Tintelnot K, Lütticken R, Haase G.

FEMS Microbiol Lett. 2000 Oct 1;191(1):151-5.

50.

The cyl genes of Streptococcus agalactiae are involved in the production of pigment.

Spellerberg B, Martin S, Brandt C, Lütticken R.

FEMS Microbiol Lett. 2000 Jul 15;188(2):125-8.

Supplemental Content

Loading ...
Support Center